Disc Medicine, Inc.
IRON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001816736
In the last 90 days, Disc Medicine, Inc. insiders filed 0 open-market purchases and 9 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $3.13B in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Disc Medicine, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 152 | 168 | +16 |
| Shares | 34.1M | 34.2M | +150.8K (+0.4%) |
| Value | $1.80B | $2.26B | +$457.0M (+25.3%) |
New holders (25)
Institutions that held Disc Medicine, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (9)
Institutions that held Disc Medicine, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 583,500 | $30.9M |
| ExodusPoint Capital Management, LP | 57,945 | $3.07M |
| Bollard Group LLC | 30,635 | $1.62M |
| Voloridge Investment Management, LLC | 19,726 | $1.04M |
| Harvest Investment Services, LLC | 14,316 | $758.2K |
| UBS Oconnor LLC | 12,317 | $652.3K |
| First Trust Advisors LP | 10,246 | $542.6K |
| HighVista Strategies LLC | 6,733 | $356.6K |
| Meeder Asset Management Inc | 2,244 | $118.8K |